1wbo: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1wbo.png|left|200px]] | [[Image:1wbo.png|left|200px]] | ||
{{STRUCTURE_1wbo| PDB=1wbo | SCENE= }} | {{STRUCTURE_1wbo| PDB=1wbo | SCENE= }} | ||
===FRAGMENT BASED P38 INHIBITORS=== | ===FRAGMENT BASED P38 INHIBITORS=== | ||
{{ABSTRACT_PUBMED_15658854}} | {{ABSTRACT_PUBMED_15658854}} | ||
==About this Structure== | ==About this Structure== | ||
[[1wbo]] is a 1 chain structure of [[Mitogen-activated protein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WBO OCA]. | |||
==See Also== | |||
*[[Mitogen-activated protein kinase|Mitogen-activated protein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015658854</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
| Line 32: | Line 23: | ||
[[Category: 38 map kinase]] | [[Category: 38 map kinase]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Inhibitor structure]] | [[Category: Inhibitor structure]] | ||
[[Category: Nuclear protein]] | [[Category: Nuclear protein]] | ||
| Line 38: | Line 28: | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 14:46, 25 July 2012
FRAGMENT BASED P38 INHIBITORS
Template:ABSTRACT PUBMED 15658854
About this Structure
1wbo is a 1 chain structure of Mitogen-activated protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Hartshorn MJ, Murray CW, Cleasby A, Frederickson M, Tickle IJ, Jhoti H. Fragment-based lead discovery using X-ray crystallography. J Med Chem. 2005 Jan 27;48(2):403-13. PMID:15658854 doi:https://dx.doi.org/10.1021/jm0495778